Daiwa Securities Group
STOK icon

Daiwa Securities Group’s Stoke Therapeutics STOK Stock Holding History

Daiwa Securities Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-175
Closed -$6K – 1415
2025
Q4 		$6K Hold
175
– – ﹤0.01% 1226
2025
Q3 		$4K Hold
175
– – ﹤0.01% 1227
2025
Q2 		$2K Hold
175
– – ﹤0.01% 1228
2025
Q1 		$1K Hold
175
– – ﹤0.01% 1254
2024
Q4 		$2K Buy
+175
New +$2.15K ﹤0.01% 1231
2023
Q4 		– Sell
-126
Closed – – 1389
2023
Q3 		$0 Hold
126
– – ﹤0.01% 1335
2023
Q2 		$1K Hold
126
– – ﹤0.01% 1298
2023
Q1 		$1K Hold
126
– – ﹤0.01% 1281
2022
Q4 		$1K Hold
126
– – ﹤0.01% 1291
2022
Q3 		$2K Hold
126
– – ﹤0.01% 1248
2022
Q2 		$2K Hold
126
– – ﹤0.01% 1255
2022
Q1 		$3K Hold
126
– – ﹤0.01% 1231
2021
Q4 		$3K Hold
126
– – ﹤0.01% 1259
2021
Q3 		$3K Buy
126
+58
+85% +$1.62K ﹤0.01% 1228
2021
Q2 		$2K Hold
68
– – ﹤0.01% 1158
2021
Q1 		$3K Hold
68
– – ﹤0.01% 1120
2020
Q4 		$4K Sell
68
-117
-63% -$5.36K ﹤0.01% 1073
2020
Q3 		$6K Hold
185
– – ﹤0.01% 1079
2020
Q2 		$4K Hold
185
– – ﹤0.01% 1128
2020
Q1 		$4K Hold
185
– – ﹤0.01% 1124
2019
Q4 		$5K Buy
+185
New +$4.65K ﹤0.01% 1107

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Daiwa Securities Group's STOK Position: Q1 2026 in Review

Daiwa Securities Group sold out of Stoke Therapeutics (STOK) in Q1 2026, closing a stake of 175 shares — an estimated $6K sold.

Daiwa Securities Group first reported a position in STOK in Q4 2019 and held it in 21 quarters. The position peaked at $6K in Q4 2025. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Daiwa Securities Group reported no remaining Stoke Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 175 Stoke Therapeutics shares in Q1 2026, an estimated $6K.
  • Daiwa Securities Group first reported a position in Stoke Therapeutics in Q4 2019 and held it in 21 quarters.
  • Daiwa Securities Group's Stoke Therapeutics position peaked at $6K in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.